Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.32) by 40.63 percent. This is a 13.64 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $1.929 million which missed the analyst consensus estimate of $2.000 million by 3.57 percent. This is a 115.72 percent increase over sales of $894.086 thousand the same period last year.